PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28579812-13	2017	Detailed analysis of the costs for GT 1 showed the treatment based on ritonavir boosted paritaprevir/ombitasvir + dasabuvir+-RBV with an average cost of $24,978 (RBV+) and $25,448 (RBV-) per patient was the most cost-effective.	dasabuvir	114-123	beta-1,4-galactosyltransferase 1	Homo sapiens	35-39